コンテンツへスキップ
Merck
  • Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.

Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.

Biochemical pharmacology (2014-07-30)
Shigeru Hishinuma, Kenta Sugawara, Yoshihiro Uesawa, Hiroyuki Fukui, Masaru Shoji
要旨

Differential binding sites for first- and second-generation antihistamines were indicated on the basis of the crystal structure of human histamine H1 receptors. In this study, we evaluated differences between the thermodynamic driving forces of first- and second-generation antihistamines for human H1 receptors and their structural determinants. The binding enthalpy and entropy of 20 antihistamines were estimated with the van't Hoff equation using their dissociation constants obtained from their displacement curves against the binding of [(3)H]mepyramine to membrane preparations of Chinese hamster ovary cells expressing human H1 receptors at various temperatures from 4°C to 37°C. Structural determinants of antihistamines for their thermodynamic binding properties were assessed by quantitative structure-activity relationship (QSAR) analyses. We found that entropy-dependent binding was more evident in second- than first-generation antihistamines, resulting in enthalpy-entropy compensation between the binding forces of first- and second-generation antihistamines. QSAR analyses indicated that enthalpy-entropy compensation was determined by the sum of degrees, maximal electrostatic potentials, water-accessible surface area and hydrogen binding acceptor count of antihistamines to regulate their affinity for receptors. In conclusion, it was revealed that entropy-dependent hydrophobic interaction was more important in the binding of second-generation antihistamines, even though the hydrophilicity of second-generation antihistamines is generally increased. Furthermore, their structural determinants responsible for enthalpy-entropy compensation were explored by QSAR analyses. These findings may contribute to understanding the fundamental mechanisms of how the affinity of ligands for their receptors is regulated.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ヒスタミン 二塩酸塩, ≥99% (TLC), powder
Supelco
(±)-クロルフェニラミン マレイン酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
ヒスタミン 二塩酸塩, ≥99.0% (AT)
Sigma-Aldrich
ジフェンヒドラミン 塩酸塩, ≥98% (HPLC)
Supelco
ジフェンヒドラミン 塩酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
USP
(±)-クロルフェニラミン マレイン酸塩, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
プロメタジン 塩酸塩
Sigma-Aldrich
テルフェナジン
Sigma-Aldrich
2-(2-ピリジル)エチルアミン, 95%
Sigma-Aldrich
(±)-クロルフェニラミン マレイン酸塩, ≥99% (perchloric acid titration)
Sigma-Aldrich
フェキソフェナジン 塩酸塩, >98% (HPLC)
Sigma-Aldrich
デスロラタジン, powder, ≥98% (HPLC)
Sigma-Aldrich
ドキセピン 塩酸塩, ~85% E-isomer basis, ≥98% (GC), 15% Z-isomer basis, powder
USP
ジフェンヒドラミン 塩酸塩, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
ピリラミン マレイン酸塩
USP
フェキソフェナジン 塩酸塩, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
ベタヒスチン 二塩酸塩, ≥98%
USP
デスロラタジン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
オロパタジン 塩酸塩, ≥98% (HPLC)
USP
オロパタジン 塩酸塩, United States Pharmacopeia (USP) Reference Standard
Supelco
プロメタジン 塩酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
オキサトミド, ≥99%
(±)-クロルフェニラミン マレイン酸塩, European Pharmacopoeia (EP) Reference Standard
Supelco
ピリラミン マレイン酸塩, Pharmaceutical Secondary Standard; Certified Reference Material